FISCHER — Fischer Medical Ventures Share Price
Last trade - 00:00- IN₹16.98bn
- IN₹17.75bn
- IN₹3.09bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 4.42 | ||
| Price to Tang. Book | 4.48 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 4.63 | ||
| EV to EBITDA | 35.46 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 11.26% | ||
| Return on Equity | 8.59% | ||
| Operating Margin | 12.67% | ||
Financial Summary
| Year End 31st Mar | Unit | 2022 | 2023 | 2024 | 2025 | 2026 | 2027E | 2028E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | n/a | 1.79 | 209.81 | 1,106.99 | 3,085.76 | n/a | n/a | 351.21% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | -81.83 | +1555.27 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Fischer Medical Ventures Limited is engaged in the manufacture of advanced magnetic resonance imaging (MRI) systems in India. The Company holds a diverse portfolio of diagnostic solutions tailored to a myriad of point-of-care diagnostic solutions, enabling healthcare providers with the tools necessary for timely and precise diagnoses. The PICA MRI system is its flagship product with its open architecture, advanced hardware platform and clinical applications that make it ideally suited for patient comfort, fast acquisition times and image quality. Its AURA delivers a complete portfolio of pulse sequences typically reserved for high-field closed-bore systems, accessible in an open architecture. Its advanced capabilities include 4D CT phased acquisition for respiratory monitoring, reducing motion artifacts and improving tumor targeting for radiotherapy. It offers advanced battery-operated handheld portable X-ray systems designed for mobility, precision, and point-of-care diagnostics.
Directors
- Ravindran Govindan CHM (74)
- Svetlana Raviwada EDR
- Khairy Jamaluddin Abu Bakar NID
- Shankar Varadharajan COO
- Sing En Chan NID
- Syed Jalaludin NID
- Jaya Singhania NID (42)
- Vivek Balasubramanian CFO
- Balaji Gandla CCO
- Last Annual
- March 31st, 2026
- Last Interim
- June 30th, 2026
- Incorporated
- March 22nd, 1993
- Public Since
- January 30th, 1995
- No. of Shareholders
- 23,662
- No. of Employees
- 16
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 698,685,470
- Address
- First Floor, Silver Sky Super Mrkt Cmplx, MUMBAI, 400067
- Web
- https://www.fischerchemic.in/index.html
- Phone
- +91 2265916655
- Auditors
- Billimoria Mehta & Co.
Latest News for FISCHER
Upcoming Events for FISCHER
Q3 2027 Fischer Medical Ventures Ltd Earnings Release
Similar to FISCHER
Avience Biomedicals
National Stock Exchange of India
Borosil Scientific
National Stock Exchange of India
Entero Healthcare Solutions
National Stock Exchange of India
Galaxy Medicare
National Stock Exchange of India
GKB Ophthalmics
National Stock Exchange of India
FAQ
As of Today at 10:40 UTC, shares in Fischer Medical Ventures are trading at IN₹24.30. This share price information is delayed by 15 minutes.
Shares in Fischer Medical Ventures last closed at IN₹24.30 and the price had moved by -74.83% over the past 365 days. In terms of relative price strength the Fischer Medical Ventures share price has underperformed the S&P BSE 100 Index by -74.51% over the past year.
There is no consensus recommendation for this security.
Find out moreThe Fischer Medical Ventures dividend yield is 0.21% based on the trailing twelve month period.
Last year, Fischer Medical Ventures paid a total dividend of IN₹0.05, and it currently has a trailing dividend yield of 0.21%. We do not have any data on when Fischer Medical Ventures is to next pay dividends.
We do not have data on when Fischer Medical Ventures is to next pay dividends. The historic dividend yield on Fischer Medical Ventures shares is currently 0.21%.
To buy shares in Fischer Medical Ventures you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹24.30, shares in Fischer Medical Ventures had a market capitalisation of IN₹16.98bn.
Here are the trading details for Fischer Medical Ventures:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: FISCHER
Based on an overall assessment of its quality, value and momentum Fischer Medical Ventures is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Fischer Medical Ventures. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -37.8%.
As of the last closing price of IN₹24.30, shares in Fischer Medical Ventures were trading -32.77% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Fischer Medical Ventures PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹24.30.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Fischer Medical Ventures' management team is headed by:
- Ravindran Govindan - CHM
- Svetlana Raviwada - EDR
- Khairy Jamaluddin Abu Bakar - NID
- Shankar Varadharajan - COO
- Sing En Chan - NID
- Syed Jalaludin - NID
- Jaya Singhania - NID
- Vivek Balasubramanian - CFO
- Balaji Gandla - CCO